Ming‐Mo Hou

3.3k citations
58 papers · 2.4k · 2 hit papers · h-index 19

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 9
    • Cancer Immunotherapy and Biomarkers 5

Ming‐Mo Hou

56 papers receiving 2.4k citations

Ming‐Mo Hou's Hit Papers

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma 2024 · 239 citations
2390+2+4Years since publication2505007501k

Peers

Ming‐Mo Hou
Comparison fields: 5 of 72
  • Hepatology 1.2k
  • Oncology 723
  • Pharmacy 32
  • Public Health, Environmental and Occupational Health 200
  • Cancer Research 54
Replace Alessandro Parisi with:
Alessandro Parisi Italy
Claudia Mucciarini Italy
Shridhar Ganpathi Iyer Singapore
Ramya Thota United States
Safi Shahda United States
Laurence P. Diggs United States
Ruth Vera Spain
Lily Lau Lai United States
Diana L. Hanna United States
Nima Nabavizadeh United States
Ming‐Mo Hou relative to Alessandro Parisi Italy Alessandro Parisi's profile →
Citations per field
00.5×5×10×12.5×
Alessandro Parisi · 1×
Citations per year

Countries citing papers authored by Ming‐Mo Hou

Since Specialization
Citations

This map shows the geographic impact of Ming‐Mo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Mo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Mo Hou more than expected).

Fields of papers citing papers by Ming‐Mo Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Mo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Mo Hou. The network helps show where Ming‐Mo Hou may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming‐Mo Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming‐Mo Hou Line = papers co-authored together Ming‐Mo Hou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
Hit paper breakdown →
20201068
2
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Hit paper breakdown →
2024239
3 2019204
4 2020119
5 202255
6 201454
7 201554
8 201743
9 201639
10 202032
11 201624
12 201724
13 202124
14 201723
15 201821
16 201620
17 201920
18 202420
19
Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma.
202219
20 202118

About Ming‐Mo Hou

Ming‐Mo Hou is a scholar working on Hepatology, Oncology, Public Health, Environmental and Occupational Health, Clinical Psychology and Obstetrics and Gynecology, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Immunotherapy and Biomarkers (5 papers), Grief, Bereavement, and Mental Health (5 papers), Esophageal Cancer Research and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Immunotherapy and Immune Responses (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Hepatology (1.2k citations), Oncology (723 citations), Pharmacy (32 citations), Public Health, Environmental and Occupational Health (200 citations) and Cancer Research (54 citations). Ming‐Mo Hou has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wen‐Chi Chou, Jen‐Shi Chen, Siew Tzuh Tang, Jason Chia-Hsun Hsieh, Wen‐Cheng Chang, Fur‐Hsing Wen, Yee Chao, Yoon‐Koo Kang, Ryoko Kuromatsu and Michihisa Moriguchi. Their work appears in journals such as Journal of Pain and Symptom Management, Annals of Oncology, Psycho-Oncology, The Oncologist and Biomedical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact